Doctors may be able to better evaluate the stage of colorectal cancer using a technique that combines two imaging systems used to make a 3-D image of the whole body, a new study suggests.
FDA was notified that Pfizer will suspend a large, Phase 3 trial evaluating the investigational cardiovascular therapy torceptrapib/atorvastatin (T/A) due to an increased rate of mortality (death) in patients receiving the combination compared to those receiving atorvastatin alone.
University of Pennsylvania alumni Ralph J. Roberts and his son Brian L. Roberts have pledged $15 million to help create the first-of-its-kind proton therapy center for the treatment of cancer.
In testimony before the Food and Drug Administration (FDA), Gregory J. Dehmer, MD, president of the Society for Cardiovascular Angiography and Interventions (SCAI), today urged a review panel to evaluate new data on the safety of drug-eluting stents (DES) from the perspective of prior developments in the history of coronary intervention, and with an appreciation for the balance of benefits and risks that guides all clinical decision-making.
The first few months of recovery from an alcohol problem are hard enough, and they’re often made worse by serious sleep problems. Now, a new study gives further evidence that insomnia and other sleep woes may actually get in the way of recovery from alcohol problems.
Researchers in the Greene Infectious Disease Laboratory at Columbia University’s Mailman School of Public Health and their colleagues in the WHO Global Laboratory Network have developed a new tool for pathogen surveillance and discovery — the GreeneChip System. The GreeneChip is the first tool to provide comprehensive, differential diagnosis of infectious diseases, including those caused by viruses, bacteria, fungi or parasites.
The December issue of the Journal of Nuclear Medicine carries specific conclusions and recommendations on how the medical community can harness the power of molecular imaging and therapy to manage diseases and improve the quality of life for patients. “Shaping the Future: The 2006 SNM Molecular Imaging Summit” provides the first-ever look at molecular imaging’s potential — as seen by medical professionals, scientists, industry representatives, and funding and regulatory officials — in a special expanded section of the society’s flagship journal.
A new study by specialists at the Johns Hopkins Children’s Center and elsewhere suggests that only one in five inner-city children with chronic asthma gets enough medicine to control dangerous flare-ups of the disease.
A group of scientists at NYU School of Medicine have devised a way to reduce amyloid beta deposition by interfering with the deadly embrace of these proteins.
Transplanted neural stem cells hold promise for reducing the destruction of dopaminergic cells that occurs in Parkinson’s disease and for replacing cells lost to the disease, scientists say.